Cardiovascular Systems, Inc. provided earnings guidance for the year ending June 30, 2023. For the year, the company expects revenue of $255 million to $265 million and net loss in a range of 9% to 11% of revenues.
Cardiovascular Systems, Inc.
Equities
CSII
US1416191062
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-4.98% | 181B | |
+2.84% | 112B | |
-2.68% | 67.92B | |
+4.53% | 50.1B | |
+8.00% | 44.27B | |
+10.41% | 40.41B | |
+25.30% | 31.95B | |
-0.17% | 25.82B | |
+20.25% | 25.29B |